PL2252263T3 - Postać galenowa do podawania tryptanów poprzez błonę śluzową policzka - Google Patents
Postać galenowa do podawania tryptanów poprzez błonę śluzową policzkaInfo
- Publication number
- PL2252263T3 PL2252263T3 PL09706112T PL09706112T PL2252263T3 PL 2252263 T3 PL2252263 T3 PL 2252263T3 PL 09706112 T PL09706112 T PL 09706112T PL 09706112 T PL09706112 T PL 09706112T PL 2252263 T3 PL2252263 T3 PL 2252263T3
- Authority
- PL
- Poland
- Prior art keywords
- active ingredient
- triptans
- transmucosal delivery
- oral transmucosal
- galenic form
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Physiology (AREA)
- Nutrition Science (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Pain & Pain Management (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Rheumatology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR0850571A FR2926721B1 (fr) | 2008-01-30 | 2008-01-30 | Forme galenique pour l'adminsitration par voie trans-muqueuse de triptans |
| EP09706112A EP2252263B1 (fr) | 2008-01-30 | 2009-01-29 | Forme galenique pour l'administration de triptans par voie trans-muqueuse buccale |
| PCT/FR2009/050134 WO2009095621A1 (fr) | 2008-01-30 | 2009-01-29 | Forme galenique pour l'administration de triptans par voie trans-muqueuse buccale |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL2252263T3 true PL2252263T3 (pl) | 2011-12-30 |
Family
ID=39766922
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL09706112T PL2252263T3 (pl) | 2008-01-30 | 2009-01-29 | Postać galenowa do podawania tryptanów poprzez błonę śluzową policzka |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US9801815B2 (pl) |
| EP (1) | EP2252263B1 (pl) |
| JP (1) | JP5435659B2 (pl) |
| CN (1) | CN101983052B (pl) |
| AT (1) | ATE516015T1 (pl) |
| BR (1) | BRPI0907203A2 (pl) |
| CA (1) | CA2713163C (pl) |
| DK (1) | DK2252263T3 (pl) |
| ES (1) | ES2369747T3 (pl) |
| FR (1) | FR2926721B1 (pl) |
| MX (1) | MX2010008285A (pl) |
| PL (1) | PL2252263T3 (pl) |
| PT (1) | PT2252263E (pl) |
| RU (1) | RU2492852C2 (pl) |
| WO (1) | WO2009095621A1 (pl) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR3000896B1 (fr) * | 2013-01-14 | 2016-08-26 | Philippe Perovitch | Forme galenique pour l'administration de principe(s) actif(s) permettant l'induction acceleree du sommeil et/ou le traitement des troubles du sommeil |
| FR3031668A1 (fr) | 2015-01-20 | 2016-07-22 | Philippe Perovitch | Dispositif d'administration d'un principe actif par voie per-muqueuse buccale. |
| FR3053244A1 (fr) | 2016-07-01 | 2018-01-05 | Philippe Perovitch | Dispositif d'administration d'au moins un principe actif par voie per-muqueuse buccale. |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4888354A (en) * | 1987-12-21 | 1989-12-19 | Theratech, Inc. | Skin penetration enhancement using free base and acid addition salt combinations of active agents |
| IT1291895B1 (it) * | 1997-04-24 | 1999-01-21 | Errekappa Euroterapici S P A | Preparazione farmaceutica fluida a base di nimesulide per uso orale e rinofaringeo |
| PL337803A1 (en) * | 1997-07-03 | 2000-09-11 | Pfizer | Pharmaceutic agents containing eletriptane hemisulphate and caffeine |
| US20040136913A1 (en) * | 1997-10-01 | 2004-07-15 | Dugger Harry A. | Buccal, polar and non-polar spray containing sumatriptan |
| GB9816556D0 (en) * | 1998-07-30 | 1998-09-30 | Pfizer Ltd | Therapy |
| US20070166336A1 (en) * | 2005-12-13 | 2007-07-19 | David Delmarre | Stable and palatable oral liquid sumatriptan compositions |
| FR2906140B1 (fr) * | 2006-09-22 | 2008-12-05 | Philippe Perovitch | Forme galenique pour l'administration par voie trans-muqueuse de principes actifs |
-
2008
- 2008-01-30 FR FR0850571A patent/FR2926721B1/fr not_active Expired - Fee Related
-
2009
- 2009-01-29 CN CN2009801038906A patent/CN101983052B/zh not_active Expired - Fee Related
- 2009-01-29 JP JP2010544764A patent/JP5435659B2/ja not_active Expired - Fee Related
- 2009-01-29 BR BRPI0907203-9A patent/BRPI0907203A2/pt not_active Application Discontinuation
- 2009-01-29 US US12/863,633 patent/US9801815B2/en active Active
- 2009-01-29 CA CA2713163A patent/CA2713163C/fr not_active Expired - Fee Related
- 2009-01-29 PL PL09706112T patent/PL2252263T3/pl unknown
- 2009-01-29 PT PT09706112T patent/PT2252263E/pt unknown
- 2009-01-29 AT AT09706112T patent/ATE516015T1/de active
- 2009-01-29 EP EP09706112A patent/EP2252263B1/fr active Active
- 2009-01-29 RU RU2010136277/15A patent/RU2492852C2/ru active
- 2009-01-29 MX MX2010008285A patent/MX2010008285A/es active IP Right Grant
- 2009-01-29 DK DK09706112.1T patent/DK2252263T3/da active
- 2009-01-29 WO PCT/FR2009/050134 patent/WO2009095621A1/fr active Application Filing
- 2009-01-29 ES ES09706112T patent/ES2369747T3/es active Active
Also Published As
| Publication number | Publication date |
|---|---|
| JP2011510962A (ja) | 2011-04-07 |
| CA2713163C (fr) | 2016-11-08 |
| JP5435659B2 (ja) | 2014-03-05 |
| PT2252263E (pt) | 2011-10-19 |
| EP2252263B1 (fr) | 2011-07-13 |
| MX2010008285A (es) | 2010-10-04 |
| CN101983052A (zh) | 2011-03-02 |
| CN101983052B (zh) | 2013-03-20 |
| EP2252263A1 (fr) | 2010-11-24 |
| ES2369747T3 (es) | 2011-12-05 |
| RU2010136277A (ru) | 2012-03-10 |
| CA2713163A1 (fr) | 2009-08-06 |
| FR2926721B1 (fr) | 2011-07-22 |
| ATE516015T1 (de) | 2011-07-15 |
| DK2252263T3 (da) | 2011-10-31 |
| US20100298401A1 (en) | 2010-11-25 |
| BRPI0907203A2 (pt) | 2015-07-14 |
| WO2009095621A1 (fr) | 2009-08-06 |
| US9801815B2 (en) | 2017-10-31 |
| FR2926721A1 (fr) | 2009-07-31 |
| RU2492852C2 (ru) | 2013-09-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2009003030A (es) | Forma galenita para la administracion por via transmucosa de principios activos. | |
| WO2008027854A3 (en) | Pharmaceutical compositions comprising hgh for oral delivery | |
| PL1998762T3 (pl) | Stałe postacie dawkowania zawierające składnik czynny o zamaskowanym smaku | |
| CL2011000642A1 (es) | Unidad de dosificacion que comprende 25 a 400 mg del acido 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxol-5-il)ciclopropanocarboxamido)-3-metilpiridin-2-il)benzoico; kit farmaceutico que comprende la unidad de dosificacion; y su uso para el tratamiento de fibrosis quistica. | |
| TN2010000152A1 (en) | Pharmaceutical compositions | |
| WO2013101897A3 (en) | Improved compositions and methods for delivery of omeprazole plus acetylsalicylic acid | |
| ATE470443T1 (de) | Indol-1-yl-essigsäurederivate | |
| NZ595467A (en) | Sublingual pharmaceutical composition comprising a neutral oil | |
| WO2007018588A8 (en) | Stable pharmaceutical composition comprising linezolid form iv | |
| UA96622C2 (ru) | Твердые лекарственные формы, которые содержат алискирен, изготовленные способом сухого гранулирования | |
| EA201390394A1 (ru) | Никотинсодержащий состав | |
| WO2008087323A3 (fr) | Forme galenique pour l'administration par voie trans-muqueuse de paracetamol | |
| MX2010004556A (es) | Formulacion farmaceutica de acido clavulanico. | |
| WO2010044097A3 (en) | Novel dosage form of paliperidone and process for preparing the same | |
| PL2252263T3 (pl) | Postać galenowa do podawania tryptanów poprzez błonę śluzową policzka | |
| MX2011006797A (es) | Una formulación para administración oral transmucósica de fármacos reductores de lípidos. | |
| WO2009084041A3 (en) | Pharmaceutical compositions of dexibuprofen | |
| MXPA05008403A (es) | Uso de acido comestible en formas de dosis solidas farmaceuticas de rapida dispersion. | |
| MA32722B1 (fr) | Formulation galénique renfermant de l'aliskirène et procédé associé de préparation par granulation par fusion-extrusion | |
| MY148266A (en) | Galenical formulations of aliskiren | |
| WO2011063775A3 (en) | Pectin complexes of sartans and pharmaceutical compositions based thereon | |
| WO2008065144A3 (en) | Galenic formulations of organic compounds | |
| TN2011000107A1 (en) | Galenical formulation comprising aliskiren and process for its preparation by melt extrusion granulation | |
| TNSN06335A1 (en) | Novel stable oral risperidone solution | |
| GR1005814B (el) | Αναβραζοντα δισκια σιταλοπραμης ή και αλατων αυτης |